MASScot does not endorse nor is affiliated with any of the content contained within these links.
- NICE consults on new guideline to identify and treat skin cancer (melanoma) earlier
NICE has developed its first guideline to reduce the numbers of people dying from the skin cancer melanoma. The draft guideline is aimed at tackling wide variation across the country in diagnosis and treatment.
Source: NICE
- PD-1 Inhibition: The Changing Treatment Paradigm for Melanoma
An increased understanding of tumor immunology has led to seven new melanoma drug approvals since 2011, including the recent approvals of the PD-1 inhibitors nivolumab (Opdivo) and pembrolizumab (Keytruda). In addition, several completed and ongoing trials show promise for the use of immunotherapies in improving survival for patients with melanoma.
Source: Onc Live
- Grant Enables Rutgers Cancer Institute of New Jersey Investigators to Explore Melanoma Metastasis (US)
The mechanism by which small cellular vesicles promote melanoma metastasis (spread of disease), will be further explored by investigators at Rutgers Cancer Institute of New Jersey and the Ernest Mario School of Pharmacy at Rutgers University. A recently-awarded $200,000 grant (R21CA185835) from the National Cancer Institute to researchers Suzie Chen, PhD, and James S. Goydos, MD, FACS, will support the work.
Source: News Wise
- Children of melanoma survivors need better sun protection
A groundbreaking new study has discovered that children of melanoma survivors are not adhering optimally to sun protection recommendations. This is concerning as sunburns are a major risk factor for melanoma, and children of survivors are at increased risk for developing the disease as adults.
Source: Oncology Nurse Advisor
- Antibiotics Efficiently Kill Skin Cancer Stem Cells
A group of researchers led by Professor Michael P. Lisanti, Director of the Breakthrough Breast Cancer Unit, have published results of a recent study in Oncotarget, whereby they demonstrate the promising effects of antibiotics on different types of cancer cells, including skin cancer.
Source: Melanoma News Today
- New Zealand's Skin Cancer Rate Called A 'Timebomb' Waiting To Explode (NZ)
A top dermatologist in New Zealand has called skin cancer in the country a “time bomb” waiting to explode on the ageing population. Dermatologists have noted an increasing number of skin cancer cases among the elderly.
Source: IB Times
- Upswing in Skin Cancer Costs (US)
The cost of treating skin cancer outpaced treatment costs for all other cancers combined by 5-fold from 2002 to 2011, according to a Centers for Disease Control and Prevention (CDC) study.
Source: Jama Network
- Inside Your Health: Mobile Applications Preventing Skin Cancer (US)
Skin cancer is the most common cancer in the U.S. Two studies released today measure the effectiveness of new technologies for preventing skin cancer. For example, taking a picture of a suspicious mole and sending it to your dermatologist.
Source: KSTP
No comments:
Post a Comment